The CTS Rotea Counterflow Centrifugation System is designed to overcome many of the problems associated with small-batch cell therapy manufacturing
Critical improvements to cell and gene therapy manufacturing can be achieved by reducing risk and hands-on time using regulation-compliant reagents and closed manufacturing systems.
Learn how closed and automated systems can reduce the risk of contamination and error, while offering the ability to process multiple products in parallel in less controlled spaces
Download an Application note to learn more about the CTS Rotea Counterflow Centrifugation System
-1.png?width=174&name=1%20(1)-1.png)
